Study of the effects of tissue reactions on the function of implanted glucose sensors

Journal of Biomedical Materials Research - Part A

Volumn 85, Issue 3, 2008, Pages 699-706

  Dungel, Paul ^a   Long, Nathan ^a   Yu, Bazhang ^a   Moussy, Yvonne ^a   Moussy, Francis ^a  

^a University of South Florida   (United States)

Author keywords

Fibrosis, inflammation; Implantable glucose sensor; Tissue reactions

Indexed keywords

ANGIOGRAPHY; DIFFUSION; GLUCOSE SENSORS; HISTOLOGY; POLYVINYL ALCOHOLS; RATS; SENSITIVITY ANALYSIS;

FIBROSIS; IMPLANTABLE GLUCOSE SENSORS; SPONGES; TISSUE REACTIONS;

TISSUE;

POLYVINYL ALCOHOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOLOGICAL MONITORING; CONTROLLED STUDY; GLUCOSE TRANSDUCER; HISTOLOGY; IMPLANT; MALE; NONHUMAN; RAT; SENSOR;

ANIMALS; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; COLLAGEN; IMPLANTS, EXPERIMENTAL; MATERIALS TESTING; MONITORING, AMBULATORY; NEOVASCULARIZATION, PHYSIOLOGIC; POLYVINYL ALCOHOL; RATS; SURGICAL SPONGES;

EID: 43049140526     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.31593     Document Type: Article

References (26)

1. Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 2004;79:992-1000.
2. Neil NJ, Perdrizet GA. Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control. Endocr Pract 2004;10(Suppl 2):46-52.
3. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986.
4. UKPDS Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-853.
5. American Diabetes Association. Implications of the diabetes control and complications trial. Diabetes Care 2003;26(Suppl 1):S25-S32.
6. Almdal T, Scharling H, Jensen JS, Vestergaard H. The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: A population-based study of 13,000 men and women with 20 years of follow-up. Arch Intern Med 2004;164:1422-1426.
7. Weinzimer SA, Doyle EA, Tamborlane WV Jr. Disease management in the young diabetic patient: Glucose monitoring, coping skills, and treatment strategies. Clin Pediatr (Phila) 2005;44:393-403.
8. Chia CW, Saudek CD. Glucose sensors: Toward closed loop insulin delivery. Endocrinol Metab Clin North Am 2004;33:175-195, xi.
9. Clark Lc Jr, Lyons C. Electrode systems for continuous monitoring in cardiovascular surgery. Ann NY Acad Sci 1962;102:29-45.
10. Magner E. Trends in electrochemical biosensors. Analyst 1998;123:1967-1970.
11. Wilson GS, Gifford R. Biosensors for real-time in vivo measurements. Biosens Bioelectron 2005;20:2388-2403.
12. Kissinger PT. Biosensors - A perspective. Biosens Bioelectron 2005;20:2512-2516.
13. Gilligan BC, Shults M, Rhodes RK, Jacobs PG, Brauker JH, Pintar TJ, Updike SJ. Feasibility of continuous long-term glucose monitoring from a subcutaneous glucose sensor in humans. Diabetes Technol Ther 2004;6:378-386.
14. Kyrolainen M, Rigsby P, Eddy S, Vadgama P. Bio-/haemocompatibility: Implications and outcomes for sensors? Acta Anaesthesiol Scand Suppl 1995;104:55-60.
15. Kerner W, Kiwit M, Linke B, Keck FS, Zier H, Pfeiffer EF. The function of a hydrogen peroxide-detecting electroenzymatic glucose electrode is markedly impaired in human subcutaneous tissue and plasma. Biosens Bioelectron 1993;8:473-482.
16. Wisniewski N, Moussy F, Reichert WM. Characterization of implantable biosensor membrane biofouling. Fresenius J Anal Chem 2000;366:611-621.
17. Thome-Duret V, Gangnerau MN, Zhang Y, Wilson GS, Reach G. Modification of the sensitivity of glucose sensor implanted into subcutaneous tissue. Diabetes Metab 1996;22:174-178.
18. Ward WK, Wood MD, Casey HM, Quinn MJ, Federiuk IF. An implantable subcutaneous glucose sensor array in ketosisprone rats: Closed loop glycemic control. Artif Organs 2005;29:131-143.
19. Rebrin K, Fischer U, Hahn von Dorsche H, von Woetke T, Abel P, Brunstein E. Subcutaneous glucose monitoring by means of electrochemical sensors: Fiction or reality? J Biomed Eng 1992;14:33-40.
20. Gerritsen M, Jansen JA, Lutterman JA. Performance of subcutaneously implanted glucose sensors for continuous monitoring. Neth J Med 1999;54:167-179.
21. Sharkawy AA, Klitzman B, Truskey GA, Reichert WM. Engineering the tissue which encapsulates subcutaneous implants. I. Diffusion properties. J Biomed Mater Res 1997;37:401-412.
22. Martson M, Viljanto J, Laippala P, Saukko P. Connective tissue formation in subcutaneous cellulose sponge implants in the rat. The effect of the size and cellulose content of the implant. Eur Surg Res 1998;30:419-425.
23. Sharkawy AA, Klitzman B, Truskey GA, Reichert WM. Engineering the tissue which encapsulates subcutaneous implants. III. Effective tissue response times. J Biomed Mater Res 1998;40:598-605.
24. Yu B, Moussy Y, Moussy F. Coil-type implantable glucose biosensor with excess enzyme loading. Front Biosci 2005;10:512-520.
25. Yu B, Long N, Moussy Y, Moussy F. A long-term flexible minimally-invasive implantable glucose biosensor based on an epoxy-enhanced polyurethane membrane. Biosens Bioelectron 2006;21:2275-2282.
26. Anderson JM. Mechanism of inflammation and infection with implanted devices cardiovasc pathol. 1993;2(Suppl 1);33S-41S.